|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tolerance of 4-amino salicylic acid enemas in patients with inflammatory bowel disease and 5-amino salicylic-induced acute pan creatitis 显示文摘 | DANIEL F SEKSIK P CACHEUX W | 2004 | Inflamm Bowel Dis2004，10，3： | 1 |
| 2 | Impact of IGF-1R/EGFR cross-talks on hepatoma cell sensitivity to gefitinib 显示文摘 | Desbois-Mouthon C Cacheux W Blivet-Van Eggelpoel MJ | 2006 | Int J Cancer2006，119，11： | 1 |
| 3 | Gefitinib, an EGFR in- hibitor,prevents hepatocellular carcinoma development in the rat liv- er with cirrhosis显示文摘 | Schifer E Housset C Cacheux W | 2005 | Hepatology2005，41，： | 1 |
| 4 | Gefitinib,an EGFR in- hibitor,prevents hepatocellular carcinoma development in the rat liver with cirrhosis 显示文摘 | Schiffer E Housset C Cacheux W | 2005 | Hepatology2005，41，2： | 1 |
| 5 | Cyclooxygenase-2 inhibi- tors down-regulate osteopontin and Nr4A2 new therapeutic targets for colorectal cancers显示文摘 | Zagani R Hamzaoui N Cacheux W | 2009 | Gastroenterology2009，137，4： | 1 |
| 6 | Role of microsat- ellite instability in the management of colorectal cancers 显示文摘 | Buecher B Cacheux W Rouleau E | 2013 | Dig Liver Dis2013，45，6： | 1 |
| 7 | Gefitinib,an EGFR inhibitor,prevents hepatocellular carcinoma development in the rat liver with cirrhosis显示文摘 | Schiffer E Housset C Cacheux W | | 0，，02： | 1 |
| 8 | Cy- clooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers 显示文摘 | ZAGANI R HAMZAOUI N CACHEUX W | 2009 | Gastroenterology2009，137，： | 1 |
| 9 | Gefitinib, an EGFR inhibitor, prevents hepatoeellular carcinoma development in the rat liver with cirrhosis显示文摘 | Sehiffer E Housset C Cacheux W | 2005 | Hepatology2005，41，2： | 1 |
| 10 | Gefitinib,an EGFR inhibitor,prevents hepatocellular carcinoma development in the rat liver with cirrhosis显示文摘 | Schiffer E Housset C Cacheux W | 2005 | Hepatology2005，41，2： | 1 |
| 11 | HHV-6-related acute liver failure in two immunocompetent adults:Favourable outcome after liver transplantation and/or ganciclovir therapy显示文摘 | Cacheux W Carbonell N Rosmorduc O | 2005 | J Interm Med2005，258，： | 1 |
| 12 | Tolerance of 4-aminosalicylic acid enemas in patients with inflammatory bowel disease and 5-aminosalicylic-induced acute pancreatitis显示文摘 | Daniel F Seksik P Cacheux W | 2004 | Inflamm Bowel Dis2004，10，3： | 1 |
| 13 | Gefitinib and the modulation of the signaling pathways downstream of epidermal growth factor receptor in human liver cancer ceils显示文摘 | E Schiffer C Housset W Cacheux | 2006 | Gastroentero12006，41，2： | 1 |
| 14 | Complex interplay between β - catenin signalling and Notch ef-fectors in intestinal tumorigenesis 显示文摘 | Peignon G Durand A Cacheux W | 2011 | Gut2011，60，1： | 1 |
| 15 | Gefitinib, an EGFRinhibitor, prevents hepatocellular carcinoma development in the ratliver with cirrhosis显示文摘 | Schiffer E Housset C Cacheux W | 2005 | Hepatology2005，41，： | 1 |
| 16 | Tolerance of 4-aminosali cylic acid enemas in patients with inflammatory bowel disease and 5 -aminosalicylic- induced acute pancreatitis 显示文摘 | Daniel F Seksik P Cacheux W | 2004 | Inflamm Bowel Dis2004，10，3： | 1 |
| 17 | Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers显示文摘 | Zagani R Hamzaoui N Cacheux W | | 0，，： | 1 |
| 18 | Reversible tumor growth acceleration following bevacizumab interruption in metastatic colorectal cancer patients scheduled for surgery 显示文摘 | Cacheux W Boisserie T Staudacher L | 2008 | Ann Oncol2008，19，9： | 1 |
| 19 | Complex interplay between beta--catenin signalling and Notch effectors in intestinal tumorigenesis 显示文摘 | Peignon G Durand A Cacheux W | 2011 | Gut2011，60，2： | 1 |
| 20 | Cyclooxygenase- 2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers显示文摘 | Zagani R Hamzaoui N Cacheux W | 2009 | Gastroenterology2009，137，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员